CLINICAL_TRIALS
trial_result
· 2019-11-22
Clinical Trial Update: Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia [Phase 2]
Summary
A Phase 2 pilot trial investigated rivaroxaban after angioplasty for critical limb ischemia; results have been posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ottawa Hospital Research Institute | Conditions: Critical Limb Ischemia | Phase 2 | Status: COMPLETED | Results posted: 2019-11-22